Moneycontrol PRO
you are here: HomeNewsDr reddys lab
dr reddys lab
Jump to
554 Results Found
  • Indian pharmaceutical industry to touch $130 billion by 2030: Dr Reddy's chairman K Satish Reddy Jul 24, 2021 08:12 PM IST

    Indian pharmaceutical industry to touch $130 billion by 2030: Dr Reddy's chairman K Satish Reddy

    Dr Reddy's Laboratories' chairman was of the opinion that the Indian pharma industry needs to develop stronger capabilities in innovation and R&D. Despite have the capabilities, Indian pharma industry do not get much global attention, he added.

  • Dr Reddy's signs licensing pact with Eli Lilly to produce COVID-19 treatment drug Baricitinib May 11, 2021 11:18 PM IST

    Dr Reddy's signs licensing pact with Eli Lilly to produce COVID-19 treatment drug Baricitinib

    The Hyderabad-based company has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly for the manufacture and marketing of the drug in India.

  • Dr Reddy’s Lab Q4 PAT may dip 13.6% YoY to Rs. 674.5 cr: Sharekhan Apr 12, 2021 08:42 PM IST

    Dr Reddy’s Lab Q4 PAT may dip 13.6% YoY to Rs. 674.5 cr: Sharekhan

    Net Sales are expected to increase by 9 percent Y-o-Y (down 1.9 percent Q-o-Q) to Rs. 4,849.3 crore, according to Sharekhan.

  • Dr. Reddy’s Lab Q3 PAT to Rs. 729.7 cr: Yash Securities Jan 22, 2021 01:02 PM IST

    Dr. Reddy’s Lab Q3 PAT to Rs. 729.7 cr: Yash Securities

    Net Sales are expected to increase by 16.5 percent Y-o-Y (up 4.3 percent Q-o-Q) to Rs. 5,121.8 crore, according to Yash Securities.

  • Dr Reddy's Lab shares fall 4% after firm shuts plants on reports of data breach Oct 22, 2020 11:13 AM IST

    Dr Reddy's Lab shares fall 4% after firm shuts plants on reports of data breach

    The company’s plants in India, Brazil, Russia, the United Kingdom and the United States were impacted by the breach which happened between 4.00-5.00 pm (US time), the report suggests.

  • Hold Dr. Reddy's Lab; target of Rs 5325: Emkay Global Financial Sep 18, 2020 04:52 PM IST

    Hold Dr. Reddy's Lab; target of Rs 5325: Emkay Global Financial

    Emkay Global Financial recommended hold rating on Dr. Reddy's Lab with a target price of Rs 5325 in its research report dated September 17, 2020.

  • Divi’s Labs an outlier in the pharma sector Aug 12, 2020 11:53 AM IST

    Divi’s Labs an outlier in the pharma sector

    Divi’s Lab is now reaping the benefits of its strategic vision

  • 5 reasons why Nomura downgraded Indian equities to ‘neutral’ Jan 14, 2020 02:09 PM IST

    5 reasons why Nomura downgraded Indian equities to ‘neutral’

    Top stocks from Nomura include ICICI Bank, Axis Bank, Larsen & Toubro and Dr. Reddy's Lab.

  • Dr. Reddy’s Lab Q3 PAT seen up 60.6% YoY to Rs. 472.4 cr: Sharekhan Jan 18, 2019 03:00 PM IST

    Dr. Reddy’s Lab Q3 PAT seen up 60.6% YoY to Rs. 472.4 cr: Sharekhan

    Net Sales are expected to increase by 1.9 percent Y-o-Y (up 2.3 percent Q-o-Q) to Rs. 3,905 crore, according to Sharekhan.

  • Dr. Reddy’s Lab Q2 PAT seen up 20.2% YoY to Rs. 356.1 cr: Sharekhan Oct 17, 2018 11:23 AM IST

    Dr. Reddy’s Lab Q2 PAT seen up 20.2% YoY to Rs. 356.1 cr: Sharekhan

    Net Sales are expected to increase by 5.3 percent Y-o-Y (up 0.4 percent Q-o-Q) to Rs. 3,750 crore, according to Sharekhan.

  • Automobile, pharma firms big beneficiaries of export incentive scheme Sep 03, 2018 12:40 PM IST

    Automobile, pharma firms big beneficiaries of export incentive scheme

    Under the Merchandise Exports from India Scheme (MEIS), the government provides duty benefits at different rates depending on product and country.

  • Hold Dr Reddy's Lab; target of Rs 2000: Centrum Research Jun 06, 2018 04:33 PM IST

    Hold Dr Reddy's Lab; target of Rs 2000: Centrum Research

    Centrum Research recommended hold rating on Dr Reddy's Lab with a target price of Rs 2000 in its research report dated May 28, 2018.

  • Dr. Reddy’s Lab Q4 PAT may dip 17.7% YoY to Rs. 269.4 cr: KR Choksey Apr 23, 2018 03:17 PM IST

    Dr. Reddy’s Lab Q4 PAT may dip 17.7% YoY to Rs. 269.4 cr: KR Choksey

    Net Sales are expected to increase by 11.1 percent Y-o-Y (down 3.7 percent Q-o-Q) to Rs. 3,663.7 crore, according to KR Choksey.

  • India Inc pay gap: CEOs earn up to 1,200-times of average staff Jul 24, 2017 07:50 AM IST

    India Inc pay gap: CEOs earn up to 1,200-times of average staff

    An analysis of remuneration disclosures made by top listed companies forming part of the blue-chip index Sensex -- under directions of the capital markets regulator Sebi -- shows that the pay packages of senior-most personnel such as CEOs and executive chairmen continue to remain high and rose further at most private sector firms during 2016-17.

  • Indian ADRs: ICICI, HDFC Bank, Tata Motors rally Sep 17, 2015 07:57 AM IST

    Indian ADRs: ICICI, HDFC Bank, Tata Motors rally

    In the technology space, Infosys rose 0.62 percent to USD 17.87 and Wipro gained 2.03 percent at USD 12.08.

  • Indian ADRs: ICICI, HDFC Bank, Infosys rally Jun 23, 2015 08:48 AM IST

    Indian ADRs: ICICI, HDFC Bank, Infosys rally

    In technology space, Infosys rose 1.97 percent to USD 32.53 and Wipro gained 0.75 percent at USD 12.09.

  • Indian ADRs: Tata Motors & Dr Reddy's gain, HDFC Bank falls May 02, 2015 11:00 AM IST

    Indian ADRs: Tata Motors & Dr Reddy's gain, HDFC Bank falls

    Indian ADRs ended mixed on Friday. In the technology space, Infosys gained 0.21 percent at USD 31.19 and Wipro rose 0.12 percent to USD 11.59 per ADR.

  • Indian ADRs: ICICI & HDFC Bank gain, Dr Reddy's falls Apr 03, 2015 10:27 AM IST

    Indian ADRs: ICICI & HDFC Bank gain, Dr Reddy's falls

    Indian ADRs closed higher on Thursday. In the banking space, ICICI Bank was up 0.66 percent to USD 10.69 and HDFC Bank gained 1.9 percent at USD 60.61 per ADR.

  • Indian ADRs: Dr Reddy's Labs, HDFC Bank rally 3% Mar 06, 2015 10:44 AM IST

    Indian ADRs: Dr Reddy's Labs, HDFC Bank rally 3%

    Indian ADRs closed higher on Thursday. In the banking space, HDFC Bank rallied 2.69 percent to USD 63.44 per ADR and rival ICICI Bank was up 0.35 percent at USD 11.59.

  • Indian ADRs: Infosys, Tata Motors, Dr Reddy's Labs decline Dec 25, 2014 08:49 AM IST

    Indian ADRs: Infosys, Tata Motors, Dr Reddy's Labs decline

    Indian ADRs ended flat with a negative bias on Wednesday. HDFC Bank fell 0.06 percent to USD 50.86 per ADR while ICICI Bank rose 0.08 percent to USD 11.65.

  • Indian ADRs: Wipro slips 1.7%, Dr Reddy's Labs rises 1% Oct 24, 2014 09:35 AM IST

    Indian ADRs: Wipro slips 1.7%, Dr Reddy's Labs rises 1%

    Tata Motors climbed 0.42 percent to USD 45.44 and Dr Reddy's Labs was up 0.94 percent at USD 50.57.

  • Indian ADRs: Tata Motors falls 2%, Infosys slips 1% Oct 17, 2014 08:52 AM IST

    Indian ADRs: Tata Motors falls 2%, Infosys slips 1%

    Among banks, HDFC Bank declined 0.40 percent to USD 47.92 and ICICI Bank was down 0.24 percent to USD 50.54 per ADR.

  • Indian ADRs: Infosys & Wipro decline, ICICI Bank gains Sep 05, 2014 08:26 AM IST

    Indian ADRs: Infosys & Wipro decline, ICICI Bank gains

    In the technology space, Infosys was down 0.11 percent to USD 61.11 and Wipro lost 0.18 percent to USD 12.19.

  • Indian ADRs: Dr Reddy's Labs soars 2%, HDFC Bank up 1.2% Mar 15, 2014 08:59 AM IST

    Indian ADRs: Dr Reddy's Labs soars 2%, HDFC Bank up 1.2%

    Indian ADRs closed higher on Friday. In the technology space, Infosys rose 0.83 percent to USD 54.95 while rival Wipro fell 1.3 percent to USD 12.86.

  • Indian ADRs: Dr Reddy's Labs falls 3.6%, Wipro slips 2.7% Mar 01, 2014 09:51 AM IST

    Indian ADRs: Dr Reddy's Labs falls 3.6%, Wipro slips 2.7%

    In the banking space, private sector lender ICICI Bank climbed 1.22 percent to USD 35.68, but its rival HDFC Bank was down 0.06 percent to USD 33.59.

Sections
ISO 27001 - BSI Assurance Mark